These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
191 related items for PubMed ID: 11213849
1. Epidemiology, resistance, and outcomes of Acinetobacter baumannii bacteremia treated with imipenem-cilastatin or ampicillin-sulbactam. Jellison TK, Mckinnon PS, Rybak MJ. Pharmacotherapy; 2001 Feb; 21(2):142-8. PubMed ID: 11213849 [Abstract] [Full Text] [Related]
2. A comparison of clinical and microbiological efficacy of antibiotic regimens against Acinetobacter baumannii. Ackerman BH, Haith LR, Patton ML, Guilday RE, Reigart CL, Stair-Buchmann M. J Burn Care Res; 2013 Feb; 34(4):403-12. PubMed ID: 23237825 [Abstract] [Full Text] [Related]
4. Comparison of efficacy of cefoperazone/sulbactam and imipenem/cilastatin for treatment of Acinetobacter bacteremia. Choi JY, Kim CO, Park YS, Yoon HJ, Shin SY, Kim YK, Kim MS, Kim YA, Song YG, Yong D, Lee K, Kim JM. Yonsei Med J; 2006 Feb 28; 47(1):63-9. PubMed ID: 16502486 [Abstract] [Full Text] [Related]
9. Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii. Corbella X, Ariza J, Ardanuy C, Vuelta M, Tubau F, Sora M, Pujol M, Gudiol F. J Antimicrob Chemother; 1998 Dec 28; 42(6):793-802. PubMed ID: 10052904 [Abstract] [Full Text] [Related]
10. Nontraditional dosing of ampicillin-sulbactam for multidrug-resistant Acinetobacter baumannii meningitis. Cawley MJ, Suh C, Lee S, Ackerman BH. Pharmacotherapy; 2002 Apr 28; 22(4):527-32. PubMed ID: 11939689 [Abstract] [Full Text] [Related]
11. Comparison of Tigecycline or Cefoperazone/Sulbactam therapy for bloodstream infection due to Carbapenem-resistant Acinetobacter baumannii. Niu T, Luo Q, Li Y, Zhou Y, Yu W, Xiao Y. Antimicrob Resist Infect Control; 2019 Apr 28; 8():52. PubMed ID: 30886705 [Abstract] [Full Text] [Related]
17. Imipenem-cilastatin versus sulbactam-cefoperazone plus amikacin in the initial treatment of febrile neutropenic cancer patients. Ozyilkan O, Yalçintaş U, Başkan S. Korean J Intern Med; 1999 Jul 28; 14(2):15-9. PubMed ID: 10461420 [Abstract] [Full Text] [Related]